Technical Analysis for AMGN - Amgen Inc.

Grade Last Price % Change Price Change
grade A 201.8 -0.45% -0.92
AMGN closed down 0.45 percent on Friday, October 19, 2018, on 1.13 times normal volume.

Earnings due: Oct 30

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Flat
See historical AMGN trend table...

Date Alert Name Type % Chg
Oct 19 20 DMA Resistance Bearish 0.00%
Oct 18 20 DMA Resistance Bearish -0.45%
Oct 18 50 DMA Support Bullish -0.45%
Oct 17 50 DMA Support Bullish -0.48%
Oct 17 Multiple of Ten Bullish Other -0.48%
Oct 16 Crossed Above 50 DMA Bullish -0.27%
Oct 16 180 Bullish Setup Bullish Swing Setup -0.27%
Oct 16 Multiple of Ten Bullish Other -0.27%
Oct 15 180 Bearish Setup Bearish Swing Setup 3.18%
Oct 15 Lower Bollinger Band Walk Weakness 3.18%

Older signals for AMGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada. Its principal products include Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body fight infections; Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases; Aranesp and EPOGEN erythropoiesis-stimulating agents that stimulate the production of red blood cells; and XGEVA/Prolia (denosumab) to treat men with castration-resistant prostate cancer at high risk of developing bone metastases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides product candidates in mid- to late-stage development in various therapeutic areas comprising oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine, which includes neuroscience. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc; Takeda Pharmaceutical Company Limited; and UCB, as well as a strategic alliance with Astellas Pharma Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Is AMGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 210.19
52 Week Low 163.31
Average Volume 2,352,460
200-Day Moving Average 187.1764
50-Day Moving Average 200.8266
20-Day Moving Average 203.744
10-Day Moving Average 200.923
Average True Range 4.0956
ADX 22.43
+DI 19.3533
-DI 20.2394
Chandelier Exit (Long, 3 ATRs ) 197.9032
Chandelier Exit (Short, 3 ATRs ) 204.6668
Upper Bollinger Band 211.8793
Lower Bollinger Band 195.6087
Percent B (%b) 0.38
BandWidth 7.985806
MACD Line -0.2302
MACD Signal Line 0.1856
MACD Histogram -0.4158
Fundamentals Value
Market Cap 147.25 Billion
Num Shares 730 Million
EPS 10.98
Price-to-Earnings (P/E) Ratio 18.38
Price-to-Sales 5.59
Price-to-Book 4.07
PEG Ratio 3.29
Dividend 4.60
Dividend Yield 2.28%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 207.31
Resistance 3 (R3) 207.80 206.46 206.39
Resistance 2 (R2) 206.46 205.06 206.21 206.08
Resistance 1 (R1) 204.13 204.19 203.46 203.64 205.78
Pivot Point 202.79 202.79 202.46 202.54 202.79
Support 1 (S1) 200.46 201.39 199.79 199.97 197.82
Support 2 (S2) 199.12 200.52 198.87 197.52
Support 3 (S3) 196.79 199.12 197.21
Support 4 (S4) 196.30